Favorable safety profile of NOAC therapy in patients after tricuspid transcatheter edge-to-edge repair
Background: Transcatheter edge-to-edge repair for severe tricuspid regurgitation (TR) is a new treatment option (t-TEER). Data on optimal antithrombotic therapy after t-TEER in patients with an indication for anticoagulation are scarce and evidence-based guideline recommendations are lacking. We sou...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2025
|
| In: |
Clinical research in cardiology
Year: 2025, Volume: 114, Issue: 7, Pages: 846-855 |
| ISSN: | 1861-0692 |
| DOI: | 10.1007/s00392-024-02517-z |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00392-024-02517-z
|
| Author Notes: | Isabel A. Hoerbrand, Martin J. Kraus, Martin Gruber, Nicolas A. Geis, Philipp Schlegel, Norbert Frey, Mathias H. Konstandin |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1907501460 | ||
| 003 | DE-627 | ||
| 005 | 20251105135508.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241104s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00392-024-02517-z |2 doi | |
| 035 | |a (DE-627)1907501460 | ||
| 035 | |a (DE-599)KXP1907501460 | ||
| 035 | |a (OCoLC)1475637104 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hörbrand, Isabel |d 1994- |e VerfasserIn |0 (DE-588)1225699673 |0 (DE-627)1745563687 |4 aut | |
| 245 | 1 | 0 | |a Favorable safety profile of NOAC therapy in patients after tricuspid transcatheter edge-to-edge repair |c Isabel A. Hoerbrand, Martin J. Kraus, Martin Gruber, Nicolas A. Geis, Philipp Schlegel, Norbert Frey, Mathias H. Konstandin |
| 264 | 1 | |c 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Zuerst veröffentlicht: 19. August 2024 | ||
| 500 | |a Gesehen am 04.11.2024 | ||
| 520 | |a Background: Transcatheter edge-to-edge repair for severe tricuspid regurgitation (TR) is a new treatment option (t-TEER). Data on optimal antithrombotic therapy after t-TEER in patients with an indication for anticoagulation are scarce and evidence-based guideline recommendations are lacking. We sought to investigate efficacy and safety of novel oral anticoagulation (NOAC) and vitamin-K-antagonists (VKA) in patients undergoing t-TEER. Methods: Among 78 consecutive patients with t-TEER of severe TR, 69 patients were identified with concomitant indication for oral anticoagulation. Outcomes of these patients treated with NOAC or VKA were compared over a median follow-up period of 327 (177–460) days. Results: Despite elevated thromboembolic and bleeding risk scores (CHA2DS2-VASc 4.2 ± 1.1, HEMORR2HAGES 3.0 ± 1.0 and HAS-BLED 2.1 ± 0.8), only one major bleeding incidence occurred under NOAC therapy. The risk for overall (NOAC 8% vs. VKA group 26%, p = 0.044) and major bleeding events (NOAC 2% vs. VKA 21%, p = 0.010) was significantly lower in the NOAC compared to the VKA group. No significant difference was found between NOAC and VKA treatment in terms of mortality (NOAC 18% vs. VKA 16%, p = 0.865) or the combined endpoint of death, heart failure hospitalization, stroke, embolism, thrombosis, myocardial infarction, and severe bleeding (NOAC 48% vs. VKA 42%, p = 0.801). A comparison between apixaban (n = 27) and rivaroxaban (n = 16) treated patients revealed no significant differences between NOAC substances (all bleeding events apixaban 7% vs. rivaroxaban 13%, p = 0.638). Conclusion: Results of this study indicate that NOACs may offer a favorable risk–benefit profile for patients with concomitant indication for anticoagulation therapy following t-TEER. | ||
| 650 | 4 | |a Bleeding | |
| 650 | 4 | |a NOAC | |
| 650 | 4 | |a Oral anticoagulation | |
| 650 | 4 | |a Transcatheter edge-to-edge repair | |
| 650 | 4 | |a Transcatheter tricuspid valve repair | |
| 650 | 4 | |a Tricuspid disease | |
| 650 | 4 | |a Tricuspid regurgitation | |
| 700 | 1 | |a Volz, Martin J. |d 1991- |e VerfasserIn |0 (DE-588)1221647512 |0 (DE-627)1738963454 |4 aut | |
| 700 | 1 | |a Gruber, Martin |d 1997- |e VerfasserIn |0 (DE-588)1347383247 |0 (DE-627)1907695559 |4 aut | |
| 700 | 1 | |a Geis, Nicolas |d 1980- |e VerfasserIn |0 (DE-588)138513988 |0 (DE-627)696681854 |0 (DE-576)307885313 |4 aut | |
| 700 | 1 | |a Schlegel, Philipp |d 1984- |e VerfasserIn |0 (DE-588)1043833781 |0 (DE-627)77097550X |0 (DE-576)395950260 |4 aut | |
| 700 | 1 | |a Frey, Norbert |e VerfasserIn |0 (DE-588)141244976 |0 (DE-627)625824075 |0 (DE-576)322969514 |4 aut | |
| 700 | 1 | |a Konstandin, Mathias |d 1976- |e VerfasserIn |0 (DE-588)12390708X |0 (DE-627)706469240 |0 (DE-576)29393701X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical research in cardiology |d Berlin : Springer, 2006 |g 114(2025), 7, Seite 846-855 |h Online-Ressource |w (DE-627)506287343 |w (DE-600)2218331-0 |w (DE-576)251097692 |x 1861-0692 |7 nnas |a Favorable safety profile of NOAC therapy in patients after tricuspid transcatheter edge-to-edge repair |
| 773 | 1 | 8 | |g volume:114 |g year:2025 |g number:7 |g pages:846-855 |g extent:10 |a Favorable safety profile of NOAC therapy in patients after tricuspid transcatheter edge-to-edge repair |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00392-024-02517-z |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20241104 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 12390708X |a Konstandin, Mathias |m 12390708X:Konstandin, Mathias |d 910000 |d 910100 |d 50000 |e 910000PK12390708X |e 910100PK12390708X |e 50000PK12390708X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 7 |y j | ||
| 998 | |g 141244976 |a Frey, Norbert |m 141244976:Frey, Norbert |d 910000 |d 910100 |e 910000PF141244976 |e 910100PF141244976 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 138513988 |a Geis, Nicolas |m 138513988:Geis, Nicolas |d 910000 |d 910100 |d 50000 |e 910000PG138513988 |e 910100PG138513988 |e 50000PG138513988 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 4 | ||
| 998 | |g 1043833781 |a Schlegel, Philipp |m 1043833781:Schlegel, Philipp |d 910000 |d 910100 |e 910000PS1043833781 |e 910100PS1043833781 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 1347383247 |a Gruber, Martin |m 1347383247:Gruber, Martin |d 50000 |e 50000PG1347383247 |k 0/50000/ |p 3 | ||
| 998 | |g 1221647512 |a Volz, Martin J. |m 1221647512:Volz, Martin J. |d 910000 |d 910100 |e 910000PV1221647512 |e 910100PV1221647512 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1225699673 |a Hörbrand, Isabel |m 1225699673:Hörbrand, Isabel |d 910000 |d 910100 |e 910000PH1225699673 |e 910100PH1225699673 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1907501460 |e 4609873168 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Favorable safety profile of NOAC therapy in patients after tricuspid transcatheter edge-to-edge repair","title_sort":"Favorable safety profile of NOAC therapy in patients after tricuspid transcatheter edge-to-edge repair"}],"note":["Zuerst veröffentlicht: 19. August 2024","Gesehen am 04.11.2024"],"origin":[{"dateIssuedDisp":"2025","dateIssuedKey":"2025"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1907501460","relHost":[{"part":{"volume":"114","extent":"10","text":"114(2025), 7, Seite 846-855","issue":"7","pages":"846-855","year":"2025"},"id":{"issn":["1861-0692"],"zdb":["2218331-0"],"eki":["506287343"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"506287343","disp":"Favorable safety profile of NOAC therapy in patients after tricuspid transcatheter edge-to-edge repairClinical research in cardiology","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["95.2006 -"],"origin":[{"publisherPlace":"Berlin","publisher":"Springer","dateIssuedKey":"2006","dateIssuedDisp":"2006-"}],"title":[{"title_sort":"Clinical research in cardiology","title":"Clinical research in cardiology"}]}],"physDesc":[{"noteIll":"Illustrationen","extent":"10 S."}],"name":{"displayForm":["Isabel A. Hoerbrand, Martin J. Kraus, Martin Gruber, Nicolas A. Geis, Philipp Schlegel, Norbert Frey, Mathias H. Konstandin"]},"id":{"eki":["1907501460"],"doi":["10.1007/s00392-024-02517-z"]},"person":[{"family":"Hörbrand","display":"Hörbrand, Isabel","given":"Isabel","role":"aut"},{"family":"Volz","display":"Volz, Martin J.","given":"Martin J.","role":"aut"},{"role":"aut","given":"Martin","display":"Gruber, Martin","family":"Gruber"},{"role":"aut","given":"Nicolas","display":"Geis, Nicolas","family":"Geis"},{"given":"Philipp","role":"aut","family":"Schlegel","display":"Schlegel, Philipp"},{"display":"Frey, Norbert","family":"Frey","given":"Norbert","role":"aut"},{"given":"Mathias","role":"aut","display":"Konstandin, Mathias","family":"Konstandin"}],"language":["eng"]} | ||
| SRT | |a HOERBRANDIFAVORABLES2025 | ||